Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Channon

Showing results (31-40 of 329) with videos related to

Pageof 33
Sort By:
Journal of Molecular and Cellular Cardiology|April 14, 2009
L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive ratsChee-Wan Lee, Dan Li, Keith M Channon, et al.
Vascular Pharmacology|August 16, 2015
Endothelial cell tetrahydrobiopterin deficiency attenuates LPS-induced vascular dysfunction and hypotensionSurawee Chuaiphichai, Anna Starr, Manasi Nandi, et al.
Mutation Research|June 3, 2008
Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular riskAlexandra Doehring, Charalambos Antoniades, Keith M Channon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2014
Fractalkine promotes human monocyte survival via a reduction in oxidative stressGemma E White, Eileen McNeill, Keith M Channon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Membrane-bound CC chemokine inhibitor 35K provides localized inhibition of CC chemokine activity in vitro and in vivoChristina A Bursill, Jenna L Cash, Keith M Channon, et al.
The Journal of Invasive Cardiology|November 3, 2005
Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein graftsDaniel J Blackman, Robin P Choudhury, Adrian P Banning, et al.
Vascular Pharmacology|April 15, 2018
Vascular wall regulator of G-protein signalling-1 (RGS-1) is required for angiotensin II-mediated blood pressure controlJyoti Patel, Surawee Chuaiphichai, Gillian Douglas, et al.
The American Journal of Cardiology|October 7, 2004
Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosisDaniel J Blackman, Italo Porto, Cheerag Shirodaria, et al.
Journal of the American Society of Nephrology : JASN|April 27, 2013
Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathyKengo Kidokoro, Minoru Satoh, Keith M Channon, et al.
Molecular Pharmacology|May 19, 2011
Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockadeGemma E White, Eileen McNeill, Ivy Christou, et al.
Pageof 33

Showing results (31-40 of 329) with videos related to

Sort By:
Pageof 33
Journal of Molecular and Cellular Cardiology|April 14, 2009
L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive ratsChee-Wan Lee, Dan Li, Keith M Channon, et al.
Vascular Pharmacology|August 16, 2015
Endothelial cell tetrahydrobiopterin deficiency attenuates LPS-induced vascular dysfunction and hypotensionSurawee Chuaiphichai, Anna Starr, Manasi Nandi, et al.
Mutation Research|June 3, 2008
Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular riskAlexandra Doehring, Charalambos Antoniades, Keith M Channon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2014
Fractalkine promotes human monocyte survival via a reduction in oxidative stressGemma E White, Eileen McNeill, Keith M Channon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Membrane-bound CC chemokine inhibitor 35K provides localized inhibition of CC chemokine activity in vitro and in vivoChristina A Bursill, Jenna L Cash, Keith M Channon, et al.
The Journal of Invasive Cardiology|November 3, 2005
Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein graftsDaniel J Blackman, Robin P Choudhury, Adrian P Banning, et al.
Vascular Pharmacology|April 15, 2018
Vascular wall regulator of G-protein signalling-1 (RGS-1) is required for angiotensin II-mediated blood pressure controlJyoti Patel, Surawee Chuaiphichai, Gillian Douglas, et al.
The American Journal of Cardiology|October 7, 2004
Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosisDaniel J Blackman, Italo Porto, Cheerag Shirodaria, et al.
Journal of the American Society of Nephrology : JASN|April 27, 2013
Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathyKengo Kidokoro, Minoru Satoh, Keith M Channon, et al.
Molecular Pharmacology|May 19, 2011
Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockadeGemma E White, Eileen McNeill, Ivy Christou, et al.
Pageof 33